PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review

May 2021 | 55 pages | ID: P3E43C593F7EN
GlobalData

Abstracts

PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

PTC Therapeutics Inc (PTC Therapeutics) discovers, develops, and markets medicines for the treatment of rare disorders. Its marketed products include Evrysdi (risdiplam) for spinal muscular atrophy; Translarna (ataluren) and Emflaza (deflazacort) are indicated for the treatment of Duchenne muscular dystrophy. The company's pipeline candidates include PTC518 for the treatment of huntington’s disease; PTC857 for treatment of vatiquinone in children with mitochondrial disease; PTC596 for the treatment of leiomyosarcoma; PTC299 for the treatment of acute myelogenous leukemia; and PTC-AADC for the treatment of aromatic L-amino acid decarboxylase deficiency. PTC Therapeutics works in collaboration with various biotechnology and pharmaceutical companies for advancing its pipeline candidates. The company operates through its subsidiaries in the US and Europe. PTC Therapeutics is headquartered in South Plainfield, New Jersey, the US.

PTC Therapeutics Inc Key Recent Developments

May 04,2021: PTC Therapeutics Provides a Corporate Update and Reports First Quarter 2021 Financial Results
Apr 20,2021: PTC Therapeutics to Host Conference Call to Discuss First Quarter 2021 Financial Results
Apr 14,2021: PTC Therapeutics launches the PTC Pinpoint Direct Program for patient-initiated genetic testing
Mar 09,2021: Spinal Muscular Atrophy (SMA) Foundation and PTC Therapeutics expand partnership to advance drug discovery and development research in regenerative medicine
Feb 25,2021: PTC Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

PTC Therapeutics Inc - Key Facts
PTC Therapeutics Inc - Key Employees
PTC Therapeutics Inc - Key Employee Biographies
PTC Therapeutics Inc - Major Products and Services
PTC Therapeutics Inc - History
PTC Therapeutics Inc - Company Statement
PTC Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
PTC Therapeutics Inc - Business Description
Product Category: Collaboration and Grant Revenue
Performance
Product Category: Net Product Revenue
Performance
Product Category: Royalty Revenue
Performance
Geographical Segment: Non-US
Performance
Geographical Segment: The US
Performance
R&D Overview
PTC Therapeutics Inc - Corporate Strategy
PTC Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
PTC Therapeutics Inc - Strengths
PTC Therapeutics Inc - Weaknesses
PTC Therapeutics Inc - Opportunities
PTC Therapeutics Inc - Threats
PTC Therapeutics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
PTC Therapeutics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 04, 2021: PTC Therapeutics Provides a Corporate Update and Reports First Quarter 2021 Financial Results
Apr 20, 2021: PTC Therapeutics to Host Conference Call to Discuss First Quarter 2021 Financial Results
Apr 14, 2021: PTC Therapeutics launches the PTC Pinpoint Direct Program for patient-initiated genetic testing
Mar 09, 2021: Spinal Muscular Atrophy (SMA) Foundation and PTC Therapeutics expand partnership to advance drug discovery and development research in regenerative medicine
Feb 25, 2021: PTC Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 16, 2021: PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences
Feb 11, 2021: PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results
Feb 04, 2021: PTC Therapeutics to Host Call to Review Results from its Study of Translarna™ (ataluren) in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
Jan 14, 2021: PTC Therapeutics opens applications for the annual STRIVE awards program and introduces a new award category
Jan 11, 2021: PTC Therapeutics provides update on R&D pipeline and commercial progress at 39th Annual J.P. Morgan Healthcare Conference

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

PTC Therapeutics Inc, Key Facts
PTC Therapeutics Inc, Key Employees
PTC Therapeutics Inc, Key Employee Biographies
PTC Therapeutics Inc, Major Products and Services
PTC Therapeutics Inc, History
PTC Therapeutics Inc, Other Locations
PTC Therapeutics Inc, Subsidiaries
PTC Therapeutics Inc, Key Competitors
PTC Therapeutics Inc, Ratios based on current share price
PTC Therapeutics Inc, Annual Ratios
PTC Therapeutics Inc, Annual Ratios (Cont...1)
PTC Therapeutics Inc, Interim Ratios
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
PTC Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

PTC Therapeutics Inc, Performance Chart (2016 - 2020)
PTC Therapeutics Inc, Ratio Charts
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021